Compare CBFV & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBFV | SMTI |
|---|---|---|
| Founded | 1901 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.1M | 208.2M |
| IPO Year | 2014 | 2008 |
| Metric | CBFV | SMTI |
|---|---|---|
| Price | $37.00 | $24.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $38.00 | $34.00 |
| AVG Volume (30 Days) | 3.7K | ★ 52.1K |
| Earning Date | 04-22-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.12% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.73 | 0.05 |
| Revenue | ★ $43,557,000.00 | $15,586,976.00 |
| Revenue This Year | $48.93 | $17.31 |
| Revenue Next Year | $7.97 | $12.48 |
| P/E Ratio | ★ $51.03 | $462.40 |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $27.49 | $16.05 |
| 52 Week High | $37.95 | $35.70 |
| Indicator | CBFV | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 59.87 | 59.26 |
| Support Level | $34.06 | $22.60 |
| Resistance Level | $37.75 | $24.01 |
| Average True Range (ATR) | 1.04 | 1.46 |
| MACD | 0.10 | 0.06 |
| Stochastic Oscillator | 82.28 | 74.26 |
CB Financial Services Incis a bank holding company headquartered in Carmichaels, Pennsylvania. The company had one reportable segment, community banking services. The Bank also has a loan production office in Allegheny County, a loan production office and a corporate center in Washington County, and an operations center in Greene County, Pennsylvania. The Bank is a community-oriented institution offering residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a variety of deposit products for individuals and businesses in its market area.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.